Literature DB >> 22584003

Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis.

Kyriaki Karavanaki1, Kostas Kakleas, Soultana Georga, Alphanastasia Bartzeliotou, George Mavropoulos, Manolis Tsouvalas, Alice Vogiatzi, Ioannis Papassotiriou, Christina Karayianni.   

Abstract

BACKGROUND: High-sensitivity C-reactive protein (hs-CRP) and pro-inflammatory cytokines have been suggested as sensitive markers of endothelial dysfunction. Our aim was to monitor plasma hs-CRP levels at different time-points and in different degrees of ketoacidosis severity, its association with cytokine levels and its role as a marker of severe ketoacidosis complications. PATIENTS AND METHODS: We studied in 38 newly diagnosed children with type 1 diabetes and ketoacidosis, aged 7.7 ± 3.1 years, hs-CRP, white blood cell count (WBC), and plasma levels of cytokines IL-1β (interleukin-1β), IL-2, IL-6, IL-8, IL-10, TNF-α (tumor necrosis factor-α) prior to and during DKA management.
RESULTS: On admission, the levels of WBC, PMN, IL-6 and IL-10 were elevated, but were all reduced within 120 h after ketoacidosis management. In the group with moderate/severe ketoacidosis, but not in mild ketoacidosis, hs-CRP levels were significantly reduced at 24h (p=0.021), WBC and IL-6 at 120 h (p=0.003), while IL-10 was prematurely reduced at 6-8h (p=0.008). Moreover hs-CRP was significantly associated with WBC (p=0.023) and IL-6 (p=0.028) on admission, with IL-6 (p=0.002) and IL-8 (p=0.014) at 24h and with IL-10 (p=0.027) at 120 h. The above were not observed in the group with mild ketoacidosis.
CONCLUSIONS: In the children with moderate/severe diabetic ketoacidosis of our study, increased levels of hs-CRP and IL-6 were observed, together with leukocytosis and neutrophilia, without the presence of infection. As hs-CRP was found to be strongly associated with the inflammatory IL-6, the prolonged elevation of hs-CRP levels in children with severe ketoacidosis could serve as a marker for the development of its severe complications.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584003     DOI: 10.1016/j.clinbiochem.2012.05.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients.

Authors:  A Oras; A Peet; T Giese; V Tillmann; R Uibo
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

2.  GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.

Authors:  Kathleen Dungan; Philip Binkley; Kwame Osei
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 3.  Respiratory failure in diabetic ketoacidosis.

Authors:  Nikifor K Konstantinov; Mark Rohrscheib; Emmanuel I Agaba; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  World J Diabetes       Date:  2015-07-25

4.  Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus.

Authors:  Gianluca Tornese; Veronica Tisato; Lorenzo Monasta; Liza Vecchi Brumatti; Giorgio Zauli; Paola Secchiero
Journal:  Acta Diabetol       Date:  2015-04-12       Impact factor: 4.280

5.  Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.

Authors:  Matthew D Campbell; Mark Walker; Michael I Trenell; Steven Luzio; Gareth Dunseath; Daniel Tuner; Richard M Bracken; Stephen C Bain; Mark Russell; Emma J Stevenson; Daniel J West
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

Review 6.  The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Yong-Chao Qiao; Yin-Ling Chen; Yan-Hong Pan; Fang Tian; Yan Xu; Xiao-Xi Zhang; Hai-Lu Zhao
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 7.  Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity.

Authors:  Kely Campos Navegantes; Rafaelli de Souza Gomes; Priscilla Aparecida Tártari Pereira; Paula Giselle Czaikoski; Carolina Heitmann Mares Azevedo; Marta Chagas Monteiro
Journal:  J Transl Med       Date:  2017-02-15       Impact factor: 5.531

8.  Serum High-Sensitivity C-Reactive Protein Levels and Response to 5 mg Tadalafil Once Daily in Patients With Erectile Dysfunction and Diabetes.

Authors:  Jung Woo Lee; Hyun Jun Park; Nam Cheol Park
Journal:  Korean J Urol       Date:  2013-12-10

9.  Determinants of deranged thyroid function parameters in children admitted for management of diabetic ketoacidosis/diabetic ketosis.

Authors:  Peng Shao; Shujuan Guo; Guimei Li; Daogang Qin; Sen Li; Ying Luan
Journal:  BMC Endocr Disord       Date:  2020-09-01       Impact factor: 2.763

10.  Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes.

Authors:  Robert Z Harms; Katie R Ostlund; Monina S Cabrera; Earline Edwards; Marisa Fisher; Nora Sarvetnick
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.